MoneyWorks4Me

Marksans Pharma informs about transcript of earnings call

25 Nov 2024 Evaluate
Marksans Pharma has informed that it enclosed earnings call transcript for Q2FY25 financial performance and strategy update.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..